Algert Global’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-713,088	Closed	-$5.41M	–	1148
2025 Q3	$5.41M	Sell	713,088 -289,722	-29%	-$2.41M	0.09%	384
2025 Q2	$8.98M	Buy	1,002,810 +42,753	+4%	+$398K	0.19%	154
2025 Q1	$7.2M	Buy	960,057 +234,752	+32%	+$1.89M	0.18%	164
2024 Q4	$5.45M	Buy	725,305 +209,096	+41%	+$1.59M	0.13%	261
2024 Q3	$3.92M	Buy	516,209 +163,076	+46%	+$1.24M	0.11%	330
2024 Q2	$2.18M	Buy	353,133 +55,311	+19%	+$305K	0.07%	444
2024 Q1	$1.51M	Sell	297,822 -38,943	-12%	-$219K	0.06%	503
2023 Q4	$2.02M	Buy	336,765 +129,670	+63%	+$751K	0.08%	415
2023 Q3	$1.47M	Sell	207,095 -84,461	-29%	-$607K	0.07%	467
2023 Q2	$2.05M	Buy	291,556 +30,570	+12%	+$245K	0.09%	376
2023 Q1	$2.18M	Buy	260,986 +103,042	+65%	+$992K	0.1%	314
2022 Q4	$1.81M	Buy	157,944 +60,817	+63%	+$758K	0.1%	325
2022 Q3	$1.22M	Buy	97,127 +19,139	+25%	+$246K	0.07%	455
2022 Q2	$825K	Buy	77,988 +9,874	+14%	+$102K	0.06%	558
2022 Q1	$1.11M	Buy	68,114 +48,058	+240%	+$771K	0.07%	482
2021 Q4	$278K	Hold	20,056	–	–	0.03%	760
2021 Q3	$288K	Buy	+20,056	New	+$316K	0.04%	774